Skip to main content
5 September 2025
Last updated:
Friday 5 September 2025
User account anon menu
Login
Register and subscribe
Search
Home
News
News
Appointments
Events
About MedNous
Who We Are
Editorial Board
Editorial Policy
Research Directory
Research Directory
Organisations
Interviewees
Terms
Topics
Contact Us
Contact Form
Menu
Breadcrumb
Home
Research Directory
Research Directory
The future of RNAi in the age of gene editing
Read more
European biotechs post modest Q2 gains
Read more
The risks of therapeutic genome editing
Read more
European biotech searches for growth capital
Read more
Janssen Oncology: When the data show durable response
Read more
Real-world evidence - the new healthcare currency
Read more
Case study - the merits of adaptive trial design
Read more
The next step for EU health technology assessment
Read more
When is one drug more effective than another?
Read more
Ipsen aspires to role as speciality oncology player
Read more
Pagination
First page
« First
Previous page
‹‹
…
Page
40
Page
41
Page
42
Page
43
Current page
44
Page
45
Page
46
Page
47
Page
48
…
Next page
››
Last page
Last »
Home
News
News
Appointments
Events
About MedNous
Who We Are
Editorial Board
Editorial Policy
Research Directory
Research Directory
Organisations
Interviewees
Terms
Topics
Contact Us
Contact Form
